or
forgot password
  • cancer clinical trials in omaha, NE

  • Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    Methodist Cancer Center Methodist Estabrook
    Omaha, Nebraska 68114
    Metastatic Breast Cancer
    Assessment of Eloquent Function in Brain Tumor Patients
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Primary Brain Tumor, Metastatic Brain Tumor
    Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Methodist Estabrook Cancer Center

    Trial Locations
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Alegent Health Lakeside Hospital
    Breast Cancer
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
    Diabetes and Endocrinology Associates, PC

    Trial Locations
    Diabetes and Endocrinology Associates, PC
    U of Nebraska Medical Center
    Cushing's Disease
    Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
    Westroads Clinical Research - Omaha

    Trial Locations
    Westroads Clinical Research - Omaha
    Creighton Cardiac Center
    Obesity, Overweight
    Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumor
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
    University of Nebraska Medica Center
    Omaha, Nebraska 68198
    Cytomegalovirus Infections
    Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Cervical Cancer, Lymphedema, Sexuality and Reproductive Issues
    NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
    Missouri Valley Cancer Consortium
    Omaha, Nebraska 68106
    Renal Cell Carcinoma
    Afatinib Expanded Access Program
    1200.45.021 Boehringer Ingelheim Investigational Site
    Omaha, Nebraska
    Carcinoma, Non-Small-Cell Lung
    Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
    University of Nebraska Medical Center

    Trial Locations
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Neurofibrosarcoma, Chondrosarcoma, Endometrial Stromal Sarcoma, Mast Cell Sarcoma, Metastatic Adult Malignant Fibrous Histiocytoma of Bone, Ovarian Carcinosarcoma, Ovarian Sarcoma, Recurrent Adult Malignant Fibrous Histiocytoma of Bone, Recurrent Adult Soft Tissue Sarcoma, Small Intestine Leiomyosarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    TELESTAR (Telotristat Etiprate for Somatostatin Analogue Refractory Carcinoid Syndrome)
    Lexicon Investigational Site
    Omaha, Nebraska 68114
    Carcinoid Syndrome
    A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Prostate Cancer
    Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot be Removed by Surgery
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Childhood Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer, Type 1 Papillary Renal Cell Carcinoma, Type 2 Papillary Renal Cell Carcinoma
    Safety and Efficacy of BKM120 in Relapsed and Refractory NHL
    University of Nebraska Medical Center Univ Nebraska
    Omaha, Nebraska 68198
    Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
    Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+ Metastatic Breast Cancer
    Methodist Cancer Center SC-1
    Omaha, Nebraska 68114
    Hormone Receptor Positive Breast Cancer
    A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Relapsed or Refractory Lymphoid Malignancies
    A 2 Part Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer
    Urology Cancer Center and GU Research Network
    Omaha, Nebraska
    Prostate Cancer
    Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    A Study of Brentuximab Vedotin in Adults Age 60 and Above With Newly Diagnosed Hodgkin Lymphoma (HL)
    Nebraska Cancer Specialists
    Omaha, Nebraska 68114
    Hodgkin Disease
    Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
    Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
    Urology Cancer Center & GU Research Network
    Omaha, Nebraska 68130
    Prostate Cancer
    Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
    Nebraska Methodist Hospital
    Omaha, Nebraska 68114
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Safety and Efficacy of CML Patients Who Switch to Nilotinib and Stop Treatment After Achieving and Sustaining MR4.5.
    Hematology & Oncology Consultants, PC Hematology & Oncology
    Omaha, Nebraska 68122-1799
    CML
    Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Stage I-III Breast Cancer
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Triple-negative Breast Cancer
    A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Omaha, Nebraska 68114
    Squamous Non Small Cell Lung Cancer
    Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
    Methodist Cancer Center
    Omaha, Nebraska 68114
    Bladder Cancer, Urothelial Carcinoma
    A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
    Oncology Hematology West PC dba Nebraska Cancer Specialists
    Omaha, Nebraska 68130
    Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma, Indolent Non-Hodgkin's Lymphoma
    S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
    Nebraska Methodist Hospital
    Omaha, Nebraska 68114
    Prostate Cancer
    ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Omaha, Nebraska 68198-7680
    Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Gallbladder, Duct Cell Adenocarcinoma of the Pancreas, Localized Unresectable Adult Primary Liver Cancer, Periampullary Adenocarcinoma, Recurrent Adult Primary Liver Cancer, Recurrent Gallbladder Cancer, Recurrent Pancreatic Cancer, Stage II Gallbladder Cancer, Stage III Pancreatic Cancer, Stage IIIA Gallbladder Cancer, Stage IIIB Gallbladder Cancer, Stage IV Pancreatic Cancer, Stage IVA Gallbladder Cancer, Stage IVB Gallbladder Cancer
    Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Hodgkin Disease
    Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Dyspnea, Non-small Cell Lung Cancer, Small Cell Lung Cancer